Skip to content
TopicTracker
From HackerNewsView original
TranslationTranslation

Curious cases of financial engineering in biotech

The article examines financial engineering practices in biotech, including milestone payments, royalty sales, and special purpose entities, showing how companies manage risk and raise capital while sometimes obscuring performance.

Related stories